Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07591571 · ClinicalTrials.gov registry record · NA

To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC

A NA study, sponsored by Loma Linda University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target

NCT07591571 is a NA study that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07591571, a NA study, is actively recruiting participants, sponsored by Loma Linda University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if a community health worker led intervention that helps facilitate palliative care works to treat newly-diagnostic pancreatic cancer. It will also help understand the impact of this intervention on people who are caregivers for patients with pancreatic cancer. The main questions it aims to answer are: Does the community health worker improve symptoms and quality of life in patients with pancreatic cancer? Does the community health worker improve the burden of caregiving and quality of life in family caregivers? Researchers will compare drug ABC to a control (where patients get the care that patients with pancreatic cancer receive including access to handouts and videos that the investigators provide patients by national organizations) to see if the intervention works to help patients with pancreatic cancer. Participants will: Meet with study staff several times over 3 months and complete surveys about their experience and symptoms Patients assigned with the community health worker will meet with them in person or video.

Interventions

  • BEHAVIORAL PAL-CHW-PDAC
  • OTHER Usual Care with Attention Control

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-09-01
Est. Completion 2026-09-01
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT07591571

The ClinicalTrials.gov registry entry for NCT07591571 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PAL-CHW-PDAC is the first listed.

NCT07591571 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07591571 about?

NCT07591571 is a clinical study titled "To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC". The goal of this clinical trial is to learn if a community health worker led intervention that helps facilitate palliative care works to treat newly-diagnostic pancreatic cancer. It will also help understand the impact of this intervention on people who are caregivers for patients with pancreatic ca...

What is the current status of trial NCT07591571?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-09-01. Estimated completion is 2026-09-01.

What interventions are being tested in trial NCT07591571?

The interventions under investigation include: PAL-CHW-PDAC (BEHAVIORAL), Usual Care with Attention Control (OTHER).

Who is sponsoring clinical trial NCT07591571?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.